Manejo de la psoriasis moderada-grave en condiciones de práctica habitual en el ámbito hospitalario español

López-Estebaranz, J.L.; Cueva‐Dobao, P. de la; Fraga, C. De La Torre; Gutiérrez, Manuel Galán; Guerra, Elena González; Sánchez, Julio; Belinchón, Isabel

doi:10.1016/j.ad.2018.02.015

Cited by 6 publications

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At this point for both diseases, it is of high importance to provide the most efficient and appropriate treatment. Health protocols have a crucial role (and in Greece authorities are working in this direction) together with the implementation of health technology assessment procedures [21][22][23] (Pain Point 3).…”

Section: Patient Journeymentioning

confidence: 99%

Patient journey pain points in spondyloarthritis and psoriasis: The case of Greece

Mechili¹,

Nikitara²,

Girvalaki³

et al. 2019

Popul. Med.

View full text Add to dashboard Cite

Despite the fact that skin disorders lead to chronicity, usually, people consider them less important than other diseases, as they are not life-threating. Evidence of the peculiarities of seronegative spondyloarthropathies (SpA) and psoriasis (including psoriatic arthritis) has increased worldwide, as indicated by the large number of recent publications on this topic 1 .SpA is a heterogeneous group of chronic inflammatory rheumatic diseases present as inflammatory back pain, asymmetric peripheral arthritis, enthesitis, dactylitis, and tenosynovitis. SpA can even cause structural complications to spine and sacroiliac joints. Genetic issues, microbial triggers, inflammation of bone marrow and enthesial structures are critical determinants of the disease 2,3 . Prevalence of SpA varies among populations and geographical areas. Worldwide prevalence is estimated to be from 0.5% to 1.9% 4 . According to the ESORDIG study, Greece has a lower prevalence of SpA compared to other countries (0.49%) 5 . However, up-to-date data are lacking, yet needed in public policy planning.Psoriasis is an autoimmune chronic inflammatory CONFLICTS OF INTERESTThe authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.

show abstract

Section: Patient Journeymentioning

confidence: 99%